$GGG
GRACO INC Stock $ggg

$ggg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000004288823000016 Filed on April 26, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$559.6M	$529.6M
YoY Change	13.22%
Cost Of Revenue	$268.2M	$244.5M
YoY Change	11.85%
Gross Profit	$291.4M	$285.1M
YoY Change	14.52%
Gross Profit Margin	52.07%	53.84%
Selling, General & Admin	$113.1M	$108.0M
YoY Change	5.65%
% of Gross Profit	38.8%	37.87%
Research & Development	$21.29M	$20.48M
YoY Change	11.57%
% of Gross Profit	7.3%	7.18%
Depreciation & Amortization	$18.13M	$17.99M
YoY Change	16.44%
% of Gross Profit	6.22%	6.31%
Operating Expenses	$134.4M	$128.5M
YoY Change	6.54%
Operating Profit	$157.1M	$156.7M
YoY Change	22.35%
Interest Expense	-$1.798M	$1.347M
YoY Change	-134.01%
% of Operating Profit	-1.14%	0.86%
Other Income/Expense, Net	$4.365M	$2.029M
YoY Change	-2952.94%
Pretax Income	$159.6M	$157.4M
YoY Change	29.85%
Income Tax	$25.35M	$28.18M
% Of Pretax Income	15.88%	17.91%
Net Earnings	$134.3M	$129.2M
YoY Change	33.15%
Net Earnings / Revenue	23.99%	24.39%
Basic Earnings Per Share	$0.80	$0.77
Diluted Earnings Per Share	$0.78	$0.75
COMMON SHARES
Basic Shares Outstanding	168.3M shares	167.8M shares
Diluted Shares Outstanding	172.6M shares	171.7M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$520.6M	$395.3M
YoY Change	36.83%
Cash & Equivalents	$520.6M	$395.3M
Short-Term Investments
Other Short-Term Assets	$44.91M	$39.43M
YoY Change	10.65%
Inventory	$479.1M	$497.2M
Prepaid Expenses
Receivables	$365.8M	$356.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.410B	$1.288B
YoY Change	17.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$709.2M	$633.5M
YoY Change	45.39%
Goodwill	$371.9M	$370.1M
YoY Change	0.13%
Intangibles	$131.1M	$134.1M
YoY Change	-14.88%
Long-Term Investments
YoY Change
Other Assets	$85.11M	$34.16M
YoY Change	139.13%
Total Long-Term Assets	$1.297B	$1.258B
YoY Change	15.6%
TOTAL ASSETS
Total Short-Term Assets	$1.410B	$1.288B
Total Long-Term Assets	$1.297B	$1.258B
Total Assets	$2.708B	$2.546B
YoY Change	16.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$81.54M	$80.38M
YoY Change	-7.45%
Accrued Expenses	$100.3M	$85.91M
YoY Change	7.26%
Deferred Revenue	$58.23M	$45.13M
YoY Change	-12.66%
Short-Term Debt	$49.10M	$41.91M
YoY Change	22.26%
Long-Term Debt Due	$75.00M
YoY Change
Total Short-Term Liabilities	$489.3M	$381.7M
YoY Change	21.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$75.00M
YoY Change	-100.0%
Other Long-Term Liabilities	$93.35M	$10.86M
YoY Change	656.18%
Total Long-Term Liabilities	$93.35M	$85.86M
YoY Change	6.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$489.3M	$381.7M
Total Long-Term Liabilities	$93.35M	$85.86M
Total Liabilities	$591.4M	$467.6M
YoY Change	20.78%
SHAREHOLDERS EQUITY
Retained Earnings	$1.154B	$1.060B
YoY Change	37.19%
Common Stock	$1.020B	$989.9M
YoY Change	9.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.116B	$1.986B
YoY Change
Total Liabilities & Shareholders Equity	$2.708B	$2.546B
YoY Change	16.74%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$134.3M	$129.2M
YoY Change	33.15%
Depreciation, Depletion And Amortization	$18.13M	$17.99M
YoY Change	16.44%
Cash From Operating Activities	$191.5M	$90.83M
YoY Change	511.31%
INVESTING ACTIVITIES
Capital Expenditures	$53.94M	$38.29M
YoY Change	14.54%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$588.0K	$352.0K
YoY Change	-538.81%
Cash From Investing Activities	-$54.53M	-$38.64M
YoY Change	-24.52%
FINANCING ACTIVITIES
Cash Dividend Paid		$39.43M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$0.00
YoY Change
Cash From Financing Activities	-11.31M	$3.319M
YoY Change	-94.43%
NET CHANGE
Cash From Operating Activities	191.5M	$90.83M
Cash From Investing Activities	-54.53M	-$38.64M
Cash From Financing Activities	-11.31M	$3.319M
Net Change In Cash	125.7M	$56.12M
YoY Change	-151.54%
FREE CASH FLOW
Cash From Operating Activities	$191.5M	$90.83M
Capital Expenditures	$53.94M	$38.29M
Free Cash Flow	$137.6M	$52.54M
YoY Change	-972.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000042888
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-29
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	168340317	shares
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	75000000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	75000000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-09249
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	GRACO INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-0285640
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	88 - 11th Avenue N.E.
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55413
CY2023Q1	dei	City Area Code CityAreaCode	(612)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	623-6000
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	GGG
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	168340317	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Revenues Revenues	529646000	usd
CY2022Q2	us-gaap	Revenues Revenues	494285000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	244506000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	239810000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	285140000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	254475000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20479000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19078000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65383000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	62995000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42610000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44039000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	156668000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	128363000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1347000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	5287000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2029000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-153000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	157350000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	122923000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28184000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22080000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	129166000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	100843000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	129166000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	100843000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4975000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2960000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-1132000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-894000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	244000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	194000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5863000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2260000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	135029000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98583000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395313000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	339196000	usd
CY2023Q1	ggg	Allowancefor Credits AllowanceforCredits	5600000	usd
CY2022Q4	ggg	Allowancefor Credits AllowanceforCredits	7000000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	356473000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	346010000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	497242000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	476790000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	39433000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43624000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1288461000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1205620000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	633482000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	607609000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	370103000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	368171000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	134131000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137507000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29742000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29785000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	56183000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	57090000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34161000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	33118000	usd
CY2023Q1	us-gaap	Assets Assets	2546263000	usd
CY2022Q4	us-gaap	Assets Assets	2438900000	usd
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	41910000	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	20974000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	80375000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	84218000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43342000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63969000	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	39457000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	39963000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	176614000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	190793000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	381698000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	399917000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75000000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	61994000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	61672000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21384000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21057000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8986000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9443000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10858000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12159000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	168308000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	167702000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	821570000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	784477000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1059980000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	976851000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-63515000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-69378000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1986343000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1859652000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2546263000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2438900000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	129166000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	100843000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17987000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15570000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	230000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	10973000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8914000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7088000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	8519000	usd
CY2022Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	14296000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18959000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	52979000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3802000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	9216000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21303000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-35341000	usd
CY2023Q1	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	1156000	usd
CY2022Q2	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-136000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-10787000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-8690000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3254000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	923000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	90829000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31325000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38290000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47093000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25016000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	352000	usd
CY2022Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	134000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-38642000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72243000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	20721000	usd
CY2022Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-3420000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	75000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6000	usd
CY2022Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31026000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21294000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7766000	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	108706000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1225000	usd
CY2022Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1219000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	39431000	usd
CY2022Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	35801000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3319000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-202852000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	611000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-45000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	56117000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-243815000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	339196000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	624302000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395313000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380487000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1859652000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	29801000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7766000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8552000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	129166000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.235
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	38925000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5863000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1986343000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1709343000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20075000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	108706000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6670000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	100843000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.210
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	35708000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2260000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1690256000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Revenues Revenues	529646000	usd
CY2022Q2	us-gaap	Revenues Revenues	494285000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	156668000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	128363000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Assets Assets	2546263000	usd
CY2022Q4	us-gaap	Assets Assets	2438900000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Revenues Revenues	529646000	usd
CY2022Q2	us-gaap	Revenues Revenues	494285000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	633482000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	607609000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	129166000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	100843000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	168018000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	169809000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3658000	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4869000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	171676000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174678000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3235000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1250000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10265000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	44.40
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7793000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	37.22
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1101000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	71.38
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	427000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	29.80
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	37000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	66.85
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10902000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	47.63
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8033000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	39.68
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8900000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7100000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	33000000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-69378000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	4975000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	888000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-63515000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80169000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2960000	usd
CY2022Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	700000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-82429000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	345000000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	11000000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	334000000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	12000000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6130000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3254000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	137000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3220000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1820000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	33000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	59000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	33000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4232000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6474000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	246401000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	222326000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	147687000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	138957000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	232913000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	248636000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	627001000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	609919000	usd
CY2023Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	129759000	usd
CY2022Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	133129000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	497242000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	476790000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	287724000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	141942000	usd
CY2023Q1	ggg	Intangible Assets Translation Adjustments IntangibleAssetsTranslationAdjustments	-11651000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	134131000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	292410000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	141960000	usd
CY2022	ggg	Intangible Assets Translation Adjustments IntangibleAssetsTranslationAdjustments	-12943000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137507000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4500000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12786000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	16311000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15849000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9050000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6406000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	12583000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	368171000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1932000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Goodwill Goodwill	370103000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	9246000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	9338000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	14917000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	14674000	usd
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8951000	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	13799000	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1055000	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	16497000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	45134000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	50747000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	27258000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	15987000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	11584000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9614000	usd
CY2023Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	18533000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	18449000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9451000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9555000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30485000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	32133000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	176614000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	190793000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	75000000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	14674000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	2392000	usd
CY2023Q1	ggg	Product Warranty Margin Reversed ProductWarrantyMarginReversed	1351000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3500000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	14917000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20600000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	22500000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	19372000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	21276000	usd
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	75000000	usd
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31

Files In Submission

Name	View Source	Status
0000042888-23-000016-index-headers.html	Edgar Link	pending
0000042888-23-000016-index.html	Edgar Link	pending
0000042888-23-000016.txt	Edgar Link	pending
0000042888-23-000016-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ggg-20230331.htm	Edgar Link	pending
ggg-20230331.xsd	Edgar Link	pending
ggg03312023exhibit991q1.htm	Edgar Link	pending
ggg2023q1ex311-quarteronly.htm	Edgar Link	pending
ggg2023q1ex312-quarteronly.htm	Edgar Link	pending
ggg2023q1ex32-quarteronly.htm	Edgar Link	pending
image0a02a.jpg	Edgar Link	pending
image1a02a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
ggg-20230331_cal.xml	Edgar Link	unprocessable
ggg-20230331_def.xml	Edgar Link	unprocessable
ggg-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ggg-20230331_pre.xml	Edgar Link	unprocessable
ggg-20230331_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GGG
GRACO INC Stock $ggg

2023 Q2 Form 10-Q Financial Statement

#000004288823000016 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GGG GRACO INC Stock $ggg

2023 Q2 Form 10-Q Financial Statement

#000004288823000016 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GGG
GRACO INC Stock $ggg